Whole genome sequencing-based copy number variations reveal novel pathways and targets in Alzheimer's disease.
Chen MingMinghui WangQian WangRyan NeffErming WangQi ShenJoseph S ReddyXue WangMariet AllenNilüfer Ertekin-TanerPhilip L De JagerDavid A BennettVahram HaroutunianEric SchadtBin ZhangPublished in: Alzheimer's & dementia : the journal of the Alzheimer's Association (2021)
We identify CNVs as potential genetic regulators of immune response in AD. The identified CNVs and their downstream gene networks reveal novel pathways and targets for AD.